Ptc Therapeutics (PTCT) Goodwill & Intangibles (2017 - 2026)
Ptc Therapeutics (PTCT) recorded quarterly Goodwill & Intangibles of $463.0 million in Q1 2026, down 1.71% quarter-over-quarter from $471.1 million in Q4 2025, and up 130.6% on a YoY basis from $200.8 million in Q1 2025.
Ptc Therapeutics (PTCT) Goodwill & Intangibles (2017 - 2026) Analysis & Trends
Ptc Therapeutics' Goodwill & Intangibles history runs 10 years deep, the most recent figure standing at $463.0 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles rose 130.6% year-over-year to $463.0 million; the TTM figure through Mar 2026 stood at $463.0 million (up 130.6% YoY), while the FY2025 annual figure was $471.1 million, up 472.13% from the prior year.
- Goodwill & Intangibles was $463.0 million for Q1 2026 at Ptc Therapeutics, down from $471.1 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $846.0 million in Q1 2022 to a low of $82.3 million in Q4 2024.
- Historically, Goodwill & Intangibles has averaged $514.0 million across 5 years, with a median of $471.1 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles tumbled 82.17% in 2024, then jumped 472.13% in 2025.
- A 5-year view of Goodwill & Intangibles shows it stood at $788.2 million in 2022, then tumbled by 41.41% to $461.8 million in 2023, then sank by 82.17% to $82.3 million in 2024, then surged by 472.13% to $471.1 million in 2025, then retreated by 1.71% to $463.0 million in 2026.
- The last three Goodwill & Intangibles figures came in at $463.0 million (Q1 2026), $471.1 million (Q4 2025), and $478.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ptc Therapeutics | 6.51 Bn | 4.61 Bn | 244.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 463.03 Mn |
| Dec 31, 2025 | 471.09 Mn |
| Sep 30, 2025 | 478.81 Mn |
| Jun 30, 2025 | 226.11 Mn |
| Mar 31, 2025 | 200.79 Mn |
| Dec 31, 2024 | 82.34 Mn |
| Sep 30, 2024 | 412.71 Mn |
| Jun 30, 2024 | 412.18 Mn |
| Mar 31, 2024 | 412.38 Mn |
| Dec 31, 2023 | 461.84 Mn |
| Sep 30, 2023 | 505.64 Mn |
| Jun 30, 2023 | 533.97 Mn |
| Mar 31, 2023 | 768.55 Mn |
| Dec 31, 2022 | 788.23 Mn |
| Sep 30, 2022 | 832.19 Mn |
| Jun 30, 2022 | 842.50 Mn |
| Mar 31, 2022 | 845.97 Mn |
| Dec 31, 2021 | 535.94 Mn |
| Sep 30, 2021 | 805.60 Mn |
| Jun 30, 2021 | 799.42 Mn |